Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries has informed the stock exchanges that its trading window will remain closed from Thursday, 1st January 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended 31st December 2025. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider trading code. During this period, directors, key managerial personnel, and other designated persons cannot trade in the company's shares. The date of the board meeting to consider the Q3 FY26 results will be communicated separately. The intimation was signed by Director Kelash Bunkar.
This is a routine regulatory filing that signals upcoming quarterly results. Shareholders should expect a board meeting announcement in the near future for Q3 FY26 results, which could be a potential catalyst for stock price movement.